CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancersSmruthi Vijayaraghavan, Khandan Keyomarsi|Nature Communications|2017Cited by 290
LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer PatientsMyLinh T. Duong, Khandan Keyomarsi|PLoS Genetics|2012Cited by 38
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancerNicole M. Kettner, Khandan Keyomarsi|npj Precision Oncology|2025Cited by 10
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 inductionLinjie Luo, Khandan Keyomarsi|Nature Communications|2026Cited by 3